Skip to main content
Log in

A case of hepatocellular carcinoma with long-term survival by multidisciplinary treatment for cranial and skeletal muscle metastases

Clinical Journal of Gastroenterology Aims and scope Submit manuscript

Abstract

We report a case in which multidisciplinary treatment was effective for hepatocellular carcinoma (HCC) with cranial and skeletal muscle metastases. A 55-year-old male with HCC received sorafenib for lung metastases. He was admitted to our hospital due to the skull metastasis detected by fluorodeoxyglucose positron emission tomography (FDG-PET). The patient underwent resection for skull metastasis. After the surgical treatment, he was treated with sorafenib again. Eight months after craniectomy, FDG-PET showed FDG uptake in the semimembranosus and semitendinosus muscles. Histopathological examination of the muscle biopsy revealed HCC muscle metastasis. Sorafenib treatment was discontinued. The investigational new drug (tegafur-gimeracil-oteracil) and tegafur-uracil were used for the treatment. These treatments proved to be ineffective as the lung metastases enlarged and new metastases appeared on the mediastinal lymph nodes and dura cava. The patient was unable to walk due to the enlarged thigh muscle metastases. Sorafenib was re-administered, which reduced the enlargement of the lung and mediastinal lymph nodes. Dural metastases were treated with resection and radiotherapy. Additional radiation therapy to the thigh muscles relieved the patient from pain experienced during walking. Sorafenib treatment was continued for the next 3 years. The patient survived for 4 years after the skull resection.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

References

  1. Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380:1450–62.

    Article  CAS  PubMed  Google Scholar 

  2. Llovet JM, Kelley RK, Villanueva A, et al. Hepatocellular carcinoma. Nat Rev Dis Primers. 2021;7:6.

    Article  PubMed  Google Scholar 

  3. Bhatia R, Ravulapati S, Befeler A, et al. Hepatocellular carcinoma with bone metastases: incidence, prognostic significance, and management-single-center experience. J Gastrointest Cancer. 2017;48:321–5.

    Article  PubMed  Google Scholar 

  4. D’Amico G, Garcia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol. 2006;44:217–31.

    Article  PubMed  Google Scholar 

  5. Hiraoka A, Michitaka K, Kumada T, et al. Validation and potential of albumin-bilirubin grade and prognostication in a nationwide survey of 46,681 hepatocellular carcinoma patients in Japan: the need for a more detailed evaluation of hepatic function. Liver Cancer. 2017;6:325–36.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Fukutomi M, Yokota M, Chuman H, et al. Increased incidence of bone metastases in hepatocellular carcinoma. Eur J Gastroenterol Hepatol. 2001;13:1083–8.

    Article  CAS  PubMed  Google Scholar 

  7. McIver JI, Scheithauer BW, Rydberg CH, et al. Metastatic hepatocellular carcinoma presenting as epidural hematoma: case report. Neurosurgery. 2001;49:447–9.

    CAS  PubMed  Google Scholar 

  8. Goto T, Dohmen T, Miura K, et al. Skull metastasis from hepatocellular carcinoma with chronic hepatitis B. World J Gastrointest Oncol. 2010;2:165–8.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Hsieh CT, Sun JM, Tsai WC, et al. Skull metastasis from hepatocellular carcinoma. Acta Neurochir (Wien). 2007;149:185–90.

    Article  Google Scholar 

  10. Kim YS, Moon KS, Lee KH, et al. Spontaneous acute epidural hematoma developed due to skull metastasis of hepatocelluar carcinoma: a case report and review of the literature. Oncol Lett. 2016;11:741–4.

    Article  PubMed  Google Scholar 

  11. Chye CL, Lin KH, Ou CH, et al. Acute spontaneous subdural hematoma caused by skull metastasis of hepatocellular carcinoma: case report. BMC Surg. 2015;15:60.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Sadik KW, Dayoub H, Bonatti H. Superior sagittal sinus tumor eroding through the skull: an unfamiliar presentation of hepatocellular carcinoma and literature review. Case Rep Surg. 2019;2019:5945726.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Chamoun RB, DeMonte F. Management of skull base metastases. Neurosurg Clin N Am. 2011;22(61–6):vi–ii.

    Google Scholar 

  14. Stark AM, Eichmann T, Mehdorn HM. Skull metastases: clinical features, differential diagnosis, and review of the literature. Surg Neurol. 2003;60:219–25 (discussion 25-6).

    Article  PubMed  Google Scholar 

  15. Soffietti R, Cornu P, Delattre JY, et al. EFNS Guidelines on diagnosis and treatment of brain metastases: report of an EFNS Task Force. Eur J Neurol. 2006;13:674–81.

    Article  CAS  PubMed  Google Scholar 

  16. Patchell RA, Tibbs PA, Regine WF, et al. Postoperative radiotherapy in the treatment of single metastases to the brain: a randomized trial. JAMA. 1998;280:1485–9.

    Article  CAS  PubMed  Google Scholar 

  17. Wu MH, Wu YM, Lee PH. The psoas muscle as an unusual site for metastasis of hepatocellular carcinoma: report of a case. Surg Today. 2006;36:280–2.

    Article  PubMed  Google Scholar 

  18. Yau T, Wong H, Chan P, et al. Intramuscular recurrence in a hepatocellular carcinoma patient with indolent disease course. World J Surg Oncol. 2008;6:42.

    Article  PubMed  PubMed Central  Google Scholar 

  19. Sano T, Izuishi K, Takebayashi R, et al. Education and imaging hepatobiliary and pancreatic: isolated diaphragmatic metastasis from hepatocellular carcinoma. J Gastroenterol Hepatol. 2009;24:1475.

    Article  CAS  PubMed  Google Scholar 

  20. Sirigu D, Loi L, Mura R, et al. Muscle metastasis from hepatocellular carcinoma in a patient treated with TACE. J Ultrasound. 2009;12:45–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Michalaki V, Zygogianni A, Kouloulias V, et al. Muscle metastasis from hepatocellular carcinoma. J Cancer Res Ther. 2011;7:81–3.

    Article  PubMed  Google Scholar 

  22. Furumoto K, Miura K, Nagashima D, et al. Solitary metastasis to the intercostal muscle from hepatocellular carcinoma: a case report. Int J Surg Case Rep. 2012;3:322–6.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Jiang H, Wang Z, Xian J, et al. Bilateral multiple extraocular muscle metastasis from hepatocellular carcinoma. Acta Radiol Short Rep. 2012;1:1–3.

    Google Scholar 

  24. Jo S, Shim HK. A patient who has survived for a long period with repeated radiotherapies for multifocal extrahepatic metastases from hepatocellular carcinoma. Radiat Oncol J. 2013;31:267–72.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Subramaniam N, Hiremath B, Pujar A. Metastasis of diffuse hepatocellular carcinoma to an extremely unusual site. BMJ Case Rep. 2013;2013:bcr2013200437.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Traficante D, Assalone P, Tomei F, et al. A case report of HCC cutaneous metastasis. J Gastrointest Oncol. 2014;5:E65–7.

    PubMed  PubMed Central  Google Scholar 

  27. Rahim EA, Noh MS, Ngah NA, et al. Hepatocellular carcinoma with disseminated skeletal muscle metastasis. Acta Radiol Open. 2017;6:2058460117716705.

    PubMed  PubMed Central  Google Scholar 

  28. Takahashi K, Putchakayala KG, Safwan M, et al. Extrahepatic metastasis of hepatocellular carcinoma to the paravertebral muscle: a case report. World J Hepatol. 2017;9:973–8.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Orita K, Sakamoto A, Okamoto T, et al. Solitary muscle metastasis of hepatocellular carcinoma to the biceps femoris muscle with only elevated serum PIVKA-II: a case report. Am J Case Rep. 2019;20:306–9.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Nakayama A, Arai J, Otoyama Y, et al. Muscular metastasis of hepatocellular carcinoma: case report and literature review. Intern Med (Tokyo, Japan). 2021. https://doi.org/10.2169/internalmedicine.7200-21.

    Article  Google Scholar 

  31. Song Q, Sun XF, Wu XL, et al. Skeletal muscle metastases of hepatocellular carcinoma: a case report and literature review. World J Clin Cases. 2021;9:3334–41.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Cha J, Seong J, Lee IJ, et al. Feasibility of sorafenib combined with local radiotherapy in advanced hepatocellular carcinoma. Yonsei Med J. 2013;54:1178–85.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  33. Guo X, Xu Y, Wang X, et al. Advanced hepatocellular carcinoma with bone metastases: prevalence, associated factors, and survival estimation. Med Sci Monit. 2019;25:1105–12.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Phillips R, Shi WY, Deek M, et al. Outcomes of observation vs stereotactic ablative radiation for oligometastatic prostate cancer: the ORIOLE phase 2 randomized clinical trial. JAMA Oncol. 2020;6:650–9.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Palma DA, Olson R, Harrow S, et al. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial. Lancet (London, England). 2019;393:2051–8.

    Article  Google Scholar 

  36. Gomez DR, Blumenschein GR Jr, Lee JJ, et al. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study. Lancet Oncol. 2016;17:1672–82.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Kim TH, Park S, Rim CH, et al. Improved oncologic outcomes by ablative radiotherapy in patients with bone metastasis from hepatocellular carcinoma. J Cancer Res Clin Oncol. 2021;147:2693–700.

    Article  PubMed  Google Scholar 

  38. Kudo M, Kawamura Y, Hasegawa K, et al. Management of hepatocellular carcinoma in Japan: JSH consensus statements and recommendations 2021 update. Liver Cancer. 2021;10:181–223.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  39. Jin K, Lan H, Wang X, et al. Genetic heterogeneity in hepatocellular carcinoma and paired bone metastasis revealed by next-generation sequencing. Int J Clin Exp Pathol. 2017;10:10495–504.

    PubMed  PubMed Central  Google Scholar 

  40. Finn RS, Qin S, Ikeda M, et al. Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma. N Engl J Med. 2020;382:1894–905.

    Article  CAS  PubMed  Google Scholar 

  41. Kudo M, Finn RS, Qin S, et al. Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial. Lancet (London, England). 2018;391:1163–73.

    Article  CAS  Google Scholar 

  42. Bruix J, Qin S, Merle P, et al. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet (London, England). 2017;389:56–66.

    Article  CAS  Google Scholar 

  43. Zhu AX, Finn RS, Galle PR, et al. Ramucirumab in advanced hepatocellular carcinoma in REACH-2: the true value of α-fetoprotein. Lancet Oncol. 2019;20: e191.

    Article  PubMed  Google Scholar 

  44. Abou-Alfa GK, Meyer T, Cheng AL, et al. Cabozantinib in patients with advanced and progressing hepatocellular carcinoma. N Engl J Med. 2018;379:54–63.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Funding

JSPS KAKENHI Grant, 20K08312, Noriyuki Akutsu.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Noriyuki Akutsu.

Ethics declarations

Conflict of interest

The authors declare that they have no conflict of interest.

Human/animal rights

All procedures followed have been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments.

Informed consent

Informed consent was obtained from the spouse of the patient for being included in the present report.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Akutsu, N., Kawakami, Y., Numata, Y. et al. A case of hepatocellular carcinoma with long-term survival by multidisciplinary treatment for cranial and skeletal muscle metastases. Clin J Gastroenterol 15, 960–967 (2022). https://doi.org/10.1007/s12328-022-01669-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12328-022-01669-7

Keywords

Navigation